Web-accessible application for identifying pathogenic transcripts with RNA-seq: Increased sensitivity in diagnosis of neurodevelopmental disorders.

[1]  L. Hoefsloot,et al.  High‐yield identification of pathogenic NF1 variants by skin fibroblast transcriptome screening after apparently normal diagnostic DNA testing , 2022, Human mutation.

[2]  E. Ashley,et al.  A guide for the diagnosis of rare and undiagnosed disease: beyond the exome , 2022, Genome medicine.

[3]  D. Baralle,et al.  MRSD: A quantitative approach for assessing suitability of RNA-seq in the investigation of mis-splicing in Mendelian disease , 2022, American journal of human genetics.

[4]  I. Blümcke,et al.  DNA methylation-based classification of malformations of cortical development in the human brain , 2021, Acta Neuropathologica.

[5]  Julius O. B. Jacobsen,et al.  The 100,000 Genomes Pilot on Rare Disease Diagnosis in Healthcare − A Preliminary Report , 2021, The New England journal of medicine.

[6]  M. Fornerod,et al.  Multidisciplinary interaction and MCD gene discovery. The perspective of the clinical geneticist. , 2021, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[7]  J. Thevenon,et al.  Phenotype associated with TAF2 biallelic mutations: A clinical description of four individuals and review of the literature. , 2021, European Journal of Medical Genetics.

[8]  M. Friez,et al.  Severe multisystem pathology, metabolic acidosis, mitochondrial dysfunction, and early death associated with an X-linked AIFM1 variant , 2021, Cold Spring Harbor molecular case studies.

[9]  B. Wirth,et al.  VPS13D: One Family, Same Mutations, Two Phenotypes , 2021, Movement disorders clinical practice.

[10]  Robert W. Taylor,et al.  Clinical implementation of RNA sequencing for Mendelian disease diagnostics , 2021, Genome Medicine.

[11]  R. Nussbaum,et al.  Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation , 2021, American journal of human genetics.

[12]  Vicente A. Yépez,et al.  Integration of proteomics with genomics and transcriptomics increases the diagnostic rate of Mendelian disorders , 2021, medRxiv.

[13]  Yue Cao,et al.  An ESCRT-dependent step in fatty acid transfer from lipid droplets to mitochondria through VPS13D−TSG101 interactions , 2021, Nature communications.

[14]  Vicente A. Yépez,et al.  Detection of aberrant splicing events in RNA-seq data using FRASER , 2021, Nature Communications.

[15]  D. Jabaudon,et al.  Mapping the molecular and cellular complexity of cortical malformations , 2021, Science.

[16]  Vicente A. Yépez,et al.  Detection of aberrant gene expression events in RNA sequencing data , 2021, Nature Protocols.

[17]  Lisha Li,et al.  How to reprogram human fibroblasts to neurons , 2020, Cell & Bioscience.

[18]  David R. Murdock,et al.  Transcriptome-directed analysis for Mendelian disease diagnosis overcomes limitations of conventional genomic testing. , 2020, The Journal of clinical investigation.

[19]  G. Carvill,et al.  Poison exons in neurodevelopment and disease. , 2020, Current opinion in genetics & development.

[20]  F. Alkuraya,et al.  Analysis of transcript-deleterious variants in Mendelian disorders: implications for RNA-based diagnostics , 2020, Genome Biology.

[21]  K. Ramzan,et al.  A de novo variant of CHD8 in a patient with autism spectrum disorder , 2020, Discoveries.

[22]  M. Shaw,et al.  Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders. , 2020, American journal of human genetics.

[23]  S. Hamada,et al.  VPS13D‐related disorders presenting as a pure and complicated form of hereditary spastic paraplegia , 2019, Molecular genetics & genomic medicine.

[24]  K. Nathanson,et al.  The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients , 2019, American journal of medical genetics. Part C, Seminars in medical genetics.

[25]  M. Fornerod,et al.  TMX2 Is a Crucial Regulator of Cellular Redox State, and Its Dysfunction Causes Severe Brain Developmental Abnormalities. , 2019, American journal of human genetics.

[26]  Y. Liu,et al.  Germline de novo variants in CSNK2B in Chinese patients with epilepsy , 2019, Scientific Reports.

[27]  Neil H. Parker,et al.  Diagnostic utility of transcriptome sequencing for rare Mendelian diseases , 2019, Genetics in Medicine.

[28]  Steven L Salzberg,et al.  Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.

[29]  D. Misceo,et al.  TBCK Encephaloneuropathy With Abnormal Lysosomal Storage: Use of a Structural Variant Bioinformatics Pipeline on Whole-Genome Sequencing Data Unravels a 20-Year-Old Clinical Mystery. , 2019, Pediatric neurology.

[30]  S. Scherer,et al.  Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders , 2019, Genetics in Medicine.

[31]  Benjamin J. Strober,et al.  Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts , 2019, Nature Medicine.

[32]  G. Schaaf,et al.  Heterogeneous clinical phenotypes and cerebral malformations reflected by rotatin cellular dynamics , 2019, Brain : a journal of neurology.

[33]  David G. Knowles,et al.  Predicting Splicing from Primary Sequence with Deep Learning , 2019, Cell.

[34]  T. Ogata,et al.  Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures , 2019, Journal of Human Genetics.

[35]  Michael A. Cortazar,et al.  How to get away with nonsense: Mechanisms and consequences of escape from nonsense‐mediated RNA decay , 2019, Wiley interdisciplinary reviews. RNA.

[36]  Arun K. Ramani,et al.  Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease. , 2019, American Journal of Human Genetics.

[37]  M. Sturm,et al.  Homozygous TBC1 domain-containing kinase (TBCK) mutation causes a novel lysosomal storage disease – a new type of neuronal ceroid lipofuscinosis (CLN15)? , 2018, Acta Neuropathologica Communications.

[38]  Arthur S. Lee,et al.  MACF1 Mutations Encoding Highly Conserved Zinc-Binding Residues of the GAR Domain Cause Defects in Neuronal Migration and Axon Guidance. , 2018, American journal of human genetics.

[39]  Jun Z. Li,et al.  Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects , 2018, Annals of neurology.

[40]  H. Prokisch,et al.  Recessive mutations in VPS13D cause childhood onset movement disorders , 2018, Annals of neurology.

[41]  Ziga Avsec,et al.  OUTRIDER: A statistical method for detecting aberrantly expressed genes in RNA sequencing data , 2018, bioRxiv.

[42]  J. Mattick,et al.  Whole genome sequencing provides better diagnostic yield and future value than whole exome sequencing , 2018, The Medical journal of Australia.

[43]  K. Kosaki,et al.  Truncating mutation in CSNK2B and myoclonic epilepsy , 2017, Human mutation.

[44]  P. Billuart,et al.  CSNK2B splice site mutations in patients cause intellectual disability with or without myoclonic epilepsy , 2017, Human mutation.

[45]  Sanjay P. Prabhu,et al.  AIFM1 mutation presenting with fatal encephalomyopathy and mitochondrial disease in an infant , 2017, Cold Spring Harbor molecular case studies.

[46]  C. Walsh,et al.  Biallelic Mutations In Human DCC Cause Developmental Split Brain Syndrome , 2017, Nature Genetics.

[47]  Thomas Meitinger,et al.  Genetic diagnosis of Mendelian disorders via RNA sequencing , 2017, Nature Communications.

[48]  Francesco Muntoni,et al.  Improving genetic diagnosis in Mendelian disease with transcriptome sequencing , 2016, Science Translational Medicine.

[49]  Raymond Dalgleish,et al.  HGVS Recommendations for the Description of Sequence Variants: 2016 Update , 2016, Human mutation.

[50]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[51]  J. Carpten,et al.  Translating RNA sequencing into clinical diagnostics: opportunities and challenges , 2016, Nature Reviews Genetics.

[52]  Liewei Wang,et al.  Measure transcript integrity using RNA-seq data , 2016, BMC Bioinformatics.

[53]  Jörg Hakenberg,et al.  Disease-associated variants in different categories of disease located in distinct regulatory elements , 2015, BMC Genomics.

[54]  Nathan Morris,et al.  Codon Optimality Is a Major Determinant of mRNA Stability , 2015, Cell.

[55]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[56]  C. Klaver,et al.  Mutations in MFSD8, encoding a lysosomal membrane protein, are associated with nonsyndromic autosomal recessive macular dystrophy. , 2015, Ophthalmology.

[57]  Jay Shendure,et al.  Disruptive CHD8 Mutations Define a Subtype of Autism Early in Development , 2014, Cell.

[58]  A. Nakashima,et al.  Identification of Regions Critical for the Integrity of the TSC1-TSC2-TBC1D7 Complex , 2014, PloS one.

[59]  J. Chrast,et al.  TBC1D7 Mutations are Associated with Intellectual Disability, Macrocrania, Patellar Dislocation, and Celiac Disease , 2014, Human mutation.

[60]  Dvir Dahary,et al.  Microcephaly thin corpus callosum intellectual disability syndrome caused by mutated TAF2. , 2013, Pediatric neurology.

[61]  Philippe P Roux,et al.  Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly , 2013, Journal of Medical Genetics.

[62]  P. Finan,et al.  TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. , 2012, Molecular cell.

[63]  Wei Li,et al.  RSeQC: quality control of RNA-seq experiments , 2012, Bioinform..

[64]  J. Veltman,et al.  De novo mutations in human genetic disease , 2012, Nature Reviews Genetics.

[65]  Peter Johnson,et al.  Prediction of single‐nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6 , 2011, Human mutation.

[66]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[67]  H. Ropers.  Genetics of early onset cognitive impairment. , 2010, Annual review of genomics and human genetics.

[68]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[69]  Xiao-qing Liu,et al.  The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter. , 2007, American journal of human genetics.

[70]  Colin A. Johnson,et al.  The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome , 2007, Nature Genetics.

[71]  M. Raponi,et al.  Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[72]  P. Bénit,et al.  AIF deficiency compromises oxidative phosphorylation , 2004, The EMBO journal.

[73]  Christopher B. Burge,et al.  RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons , 2004, Nucleic Acids Res..

[74]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[75]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[76]  R. Snell,et al.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.